LifeCycle Pharma Passing of Annual General Meeting - Subsequent Constitution of the Board of Directors, Appointment of Executive (Registered) Officers and Grant of Warrants to Executive Management and Employees

H0RSHOLM, Denmark--(BUSINESS WIRE)--Summary: At LifeCycle Pharma A/S’ Annual General Meeting held earlier today, the annual report was approved and discharge was given to the Board of Directors and the Management. All proposals from the Board of Directors were adopted. After the Annual General Meeting, the Board convened and appointed new executive (registered) managers and granted a total of 1,036,906 warrants to the executive management and employees.